Spinal cord stimulators are often promoted as an option for chronic pain, but their effectiveness in adhesive arachnoiditis is far more complex. This series explores what current evidence really shows, how paddle and percutaneous systems differ, the risks patients should understand, and how new technology may — or may not — change outcomes for those living with severe nerve root inflammation and scarring.
